AGIO Agios Pharmaceuticals, Inc. - Common Stock
$35.43
가격 · 8월 19, 2026
기준 재무 정보 7월 30, 2026
52주 범위
$22–$46
56% of range
애널리스트 평점
BUY
16 analysts
목표 주가
$46
+29% upside
P/E (TTM)
-6432.7
ROE
-32.2%
순이익률
-764.0%
Agios Pharmaceuticals, Inc. - Common Stock 정보 위키백과 회사 개요
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
더 보기
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
History
In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering Agios $120 million in drug licensing payments.
In April 2017, the company raised $250 million in a new stock offering in anticipation of approval for its first cancer drug, enasidenib, by the US Food and Drug Administration.
In December 2017, the company filed a New Drug Application with the US FDA for ivosidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with an IDH1 mutation.
In November 2019, Agios announced an underwritten public offering of 8,250,000 shares of common stock at a price of $31.00 per share which would result in approximately $256 million aggregate gross proceeds.
In April 2022, the FDA approved mitapivat as first disease-modifying therapy for hemolytic anemia in adults with pyruvate kinase deficiency.
Corporate governance
As of August 2022, Agios' CEO is Brian Goff.
Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.
== References ==
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
AGIO 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$35.43
시가총액
$2.68T
P/E (TTM)
-6432.7
EPS (TTM)
$-7.12
매출 (TTM)
$54M
배당 수익률
—
ROE
-32.2%
부채/자본
—
52주 범위
$22 – $46
AGIO 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$54M
2016-12-31
→
2025-12-31
EPS
$-7.12
2019-12-31
→
2025-12-31
잉여현금흐름
$-377M
2016-12-31
→
2025-12-31
마진
-764.0%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
AGIO
동종업계 중앙값
P/E (TTM)
-6432.7
27.2
P/S (TTM)
49548.7
25.4
P/B
2243.8
5.1
Price / FCF (주가 / FCF)
-7095.3
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
AGIO
동종업계 중앙값
Operating Margin (영업이익률)
-873.9%
—
Net Profit Margin (순이익률)
-764.0%
-473.7%
ROA
-27.9%
-40.2%
ROE
-32.2%
-50.4%
ROIC
-39.5%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
AGIO
동종업계 중앙값
Current Ratio (유동비율)
11.5
9.0
Quick Ratio (당좌 비율)
1.1
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
AGIO
동종업계 중앙값
Revenue YoY (매출 YoY)
48.0%
—
Revenue CAGR 3Y (매출 CAGR 3년)
56.0%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
AGIO
동종업계 중앙값
AGIO 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
16 명의 애널리스트
- 적극 매수 5 31.2%
- 매수 7 43.8%
- 보유 4 25.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
8 명의 애널리스트 · 2026-08-16
중앙값
$42.50
지금
$35.43
저가
$32.00
고가
$73.00
중앙값 목표
$42.50
+20.0%
평균 목표
$45.75
+29.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.10%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-1.69 | $-1.70 | 0.01% |
| 2026년 3월 31일 | $-1.69 | $-1.84 | 0.15% |
| 2025년 12월 31일 | $-1.86 | $-1.99 | 0.13% |
| 2025년 9월 30일 | $-1.78 | $-1.94 | 0.16% |
| 2025년 6월 30일 | $-1.93 | $-1.84 | -0.09% |
| 2025년 3월 31일 | $-1.55 | $-1.82 | 0.27% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| GENB | — | — | — | — | — | — |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Cost of Revenue | $6M | $4M | $3M | $2M | $0 | $0 | $1M | $1M | $0 | $0 | · | · | |
| R&D Expense | $340M | $301M | $296M | $280M | $257M | $221M | $214M | $341M | $293M | $220M | $142M | $100M | |
| SG&A Expense | $180M | $157M | $120M | $122M | $121M | $115M | $102M | $114M | $71M | $51M | $36M | $19M | |
| Operating Expenses | $526M | $462M | $418M | $403M | $378M | $336M | $316M | $457M | $364M | $271M | $178M | $119M | |
| Operating Income | $-472M | $-426M | $-391M | $-389M | $-378M | $-336M | $-316M | $-362M | $-321M | $-201M | $-119M | $-54M | |
| Interest Income | · | · | · | $13M | $836.0K | $7M | $15M | $16M | $6M | $3M | $968.0K | $203.0K | |
| Other Non-op | $2M | $6M | $6M | $7M | $14M | $0 | $0 | · | · | · | · | · | |
| Pretax Income | $-414M | $718M | $-352M | $-232M | $-357M | $-329M | $-301M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Income Tax | $-1M | $44M | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-426.0K | |
| Net Income | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| EPS (Basic) | $-7.12 | $11.86 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| EPS (Diluted) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| Shares (Basic) | 57,972,004 | 56,807,415 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| Shares (Diluted) | 57,972,004 | 57,889,255 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| EBITDA | $-472M | $-426M | $-391M | $-389M | $-378M | $-316M | $-418M | $-362M | $-321M | $-201M | $-119M | $-54M |
대차대조표 22
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $76M | $88M | $139M | $203M | $127M | $81M | $71M | $103M | $161M | $72M | $14M | |
| Short-term Investments | · | · | · | · | · | · | · | $515M | $321M | $381M | · | · | |
| Inventory | $33M | $28M | $19M | $8M | $0 | $15M | $7M | $869.0K | $0 | · | · | · | |
| Prepaid Expense | $44M | $40M | $35M | $39M | $40M | $16M | $24M | $17M | $18M | $10M | $9M | $5M | |
| Current Assets | $942M | $966M | $834M | $833M | $1.06B | $637M | $612M | $614M | $445M | $560M | $337M | $360M | |
| PP&E (Net) | $11M | $12M | $15M | $23M | $29M | $31M | $31M | $24M | $24M | $25M | $23M | $6M | |
| PP&E (Gross) | $71M | $68M | $68M | $73M | $74M | $72M | $64M | $50M | $44M | $39M | $31M | $12M | |
| Accum. Depreciation | $60M | $56M | $52M | $50M | $45M | $41M | $32M | $26M | $19M | $13M | $8M | $6M | |
| Other Non-current Assets | $4M | $5M | $4M | $4M | $3M | $0 | $0 | $238.0K | $891.0K | $2M | $611.0K | $590.0K | |
| Total Assets | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Accounts Payable | $18M | $17M | $10M | $19M | $17M | $18M | $22M | $18M | $23M | $17M | $15M | $11M | |
| Accrued Liabilities | $45M | $47M | $43M | $30M | $32M | $31M | $53M | $42M | $34M | $32M | $16M | $14M | |
| Current Liabilities | $82M | $81M | $68M | $63M | $60M | $94M | $93M | $94M | $95M | $88M | $53M | $61M | |
| Capital Leases | $22M | $40M | $57M | $72M | $86M | $97M | $106M | · | · | · | · | · | |
| Other Non-current Liabilities | $90.0K | $880.0K | $1M | $3M | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $104M | $122M | $126M | $138M | $146M | $453M | $250M | $171M | $239M | $261M | · | · | |
| Common Stock | · | · | · | · | $71.0K | $69.0K | $68.0K | $58.0K | $49.0K | $42.0K | $38.0K | $37.0K | |
| Retained Earnings | $-562M | $-149M | $-823M | $-471M | $-239M | $-1.84B | $-1.52B | $-1.10B | $-798M | $-483M | $-285M | $-167M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $0 | · | · | · | · | · | · | |
| Stockholders' Equity | $1.19B | $1.54B | $811M | $1.10B | $1.29B | $400M | $641M | $688M | $376M | $359M | $345M | $424M | |
| Liabilities + Equity | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Shares Outstanding | 58,448,592 | 73,372,696,000 | 72,161,489 | 71,256,118 | 70,550,631 | 69,293,920 | 68,401,105 | 58,218,653 | 48,826,153 | 42,220,444 | 37,696,502 | 37,100,513 |
현금 흐름 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $8M | $7M | $6M | · | · | · | |
| Stock-based Comp | $53M | $43M | $45M | $49M | $54M | $62M | $58M | $73M | $48M | $42M | $32M | $12M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | · | · | · | $-40M | · | · | · | · | · | |
| Operating Cash Flow | $-373M | $-390M | $-296M | $-309M | $-407M | $-291M | $-371M | $-304M | $-285M | $39M | $-77M | $-59M | |
| CapEx | $4M | $2M | $999.0K | $5M | $6M | $14M | $12M | $7M | $5M | $10M | $20M | $2M | |
| Investing Cash Flow | $377M | $363M | $240M | $243M | $1.25B | $76M | $91M | $-274M | $-58M | $-119M | $128M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | $0 | $334M | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | · | $334M | |
| Financing Cash Flow | $9M | $14M | $5M | $2M | $-766M | $262M | $290M | $546M | $285M | $170M | $6M | · | |
| Net Change in Cash | $13M | $-12M | $-51M | $-64M | $76M | $47M | $10M | $-32M | $-58M | $89M | $58M | $-58M | |
| Taxes Paid | $628.0K | $43M | $2M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-377M | $-392M | $-297M | $-314M | $-413M | $-306M | $-383M | $-311M | $-290M | $29M | $-97M | $-62M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -361.6% | · | -745.8% | · | · | -82.8% | |
| Net Margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | · | -161.1% | -349.0% | · | -731.6% | · | · | -81.9% | |
| Pretax Margin | -765.9% | 1967.2% | -1312.6% | -1627.8% | · | -161.2% | -349.0% | · | -731.6% | · | · | -82.5% | |
| EBITDA Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -354.7% | · | -745.8% | · | · | -82.8% | |
| ROA | -27.9% | 51.8% | -32.4% | -17.3% | 140.1% | -37.5% | -47.0% | -47.0% | -51.0% | -38.2% | -25.8% | -15.4% | |
| ROE | -32.2% | 42.5% | -41.5% | -21.6% | 119.4% | -74.4% | -75.6% | -47.8% | -85.7% | -56.4% | -30.6% | -19.2% | |
| ROIC | -39.5% | -25.9% | · | · | · | · | -66.6% | -52.7% | -85.4% | · | · | -12.7% |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 | 6.7 | 6.6 | 6.6 | 4.7 | 6.3 | 6.4 | 5.9 | |
| Quick Ratio | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 | 1.4 | 0.9 | 6.3 | 4.5 | 1.8 | 1.4 | 0.2 |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.1 | · | 0.1 | · | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | 0.2 | 0.4 | · | 0.3 | 0.3 | 3.2 | · | · | · | · |
성장률 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.0% | 36.1% | 88.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 56.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -24.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -25.1% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Net Income TTM | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Market Cap | $1.59B | $1.88B | $1.25B | $1.55B | $1.79B | $3.00B | $3.27B | $2.68B | $2.79B | $1.76B | $2.45B | $4.16B | |
| P/E | -3.8 | 2.8 | -3.5 | -6.6 | 1.2 | -9.1 | -7.0 | · | · | · | · | -70.5 | |
| P/S | 29.4 | 51.5 | 46.4 | 108.5 | · | · | 27.7 | 28.4 | 64.9 | 25.2 | 41.4 | 63.6 | |
| P/B | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | 5.1 | 3.9 | 7.4 | 4.9 | 7.1 | 9.8 | |
| P / Tangible Book | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | · | · | · | · | · | · | |
| P / Cash Flow | -4.3 | -4.8 | -4.2 | -5.0 | -4.4 | -10.3 | -8.8 | -8.8 | -9.8 | 45.7 | -31.8 | -70.0 | |
| P / FCF | -4.2 | -4.8 | -4.2 | -4.9 | -4.3 | -9.8 | -8.5 | -8.6 | -9.6 | 61.5 | -25.2 | -67.5 | |
| Earnings Yield | -26.2% | 35.4% | -28.4% | -15.1% | 80.8% | -10.9% | -14.4% | · | · | · | · | -1.4% |
손익계산서 15
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $21M | $20M | $13M | $12M | $9M | $11M | $9M | $9M | $8M | $7M | $7M | $7M | $6M | $4M | $4M | |
| Cost of Revenue | $3M | $1M | $2M | $2M | $2M | $1M | $1M | $783.0K | $1M | $627.0K | $586.0K | $633.0K | $1M | $554.0K | $413.0K | $517.0K | |
| R&D Expense | $101M | $81M | $88M | $87M | $92M | $73M | $83M | $72M | $77M | $69M | $77M | $82M | $69M | $67M | $70M | $65M | |
| SG&A Expense | $52M | $48M | $52M | $41M | $46M | $42M | $52M | $39M | $36M | $31M | $35M | $26M | $30M | $28M | $33M | $29M | |
| Operating Expenses | $155M | $131M | $142M | $130M | $140M | $115M | $136M | $112M | $114M | $100M | $113M | $108M | $100M | $96M | $103M | $95M | |
| Operating Income | $-111M | $-110M | $-122M | $-117M | $-127M | $-107M | $-125M | $-103M | $-106M | $-92M | $-106M | $-101M | $-94M | $-91M | $-99M | $-91M | |
| Other Non-op | $119.0K | $119.0K | $113.0K | $67.0K | $523.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | |
| Pretax Income | · | · | $-109M | $-103M | · | · | $-105M | $1.00B | · | · | $-96M | $-91M | · | · | · | · | |
| Income Tax | · | · | $-1M | $0 | · | · | $-9M | $53M | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Income | $-101M | $-99M | $-108M | $-103M | $-112M | $-89M | $-97M | $948M | $-96M | $-82M | $-96M | $-91M | $-84M | $-81M | $37M | $-82M | |
| EPS (Basic) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.65 | $16.65 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| EPS (Diluted) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.44 | $16.22 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| Shares (Basic) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,318,009 | 56,939,403 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| Shares (Diluted) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,729,562 | 58,432,796 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| EBITDA | $-111M | $-110M | · | $-117M | $-127M | $-107M | · | $-103M | $-106M | $-92M | · | $-101M | $-94M | $-91M | · | $-91M |
대차대조표 20
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $114M | $89M | $93M | $81M | $79M | $76M | $254M | $85M | $119M | · | $64M | $85M | $104M | · | $122M | |
| Inventory | $36M | $35M | $33M | $32M | $31M | $30M | $28M | $26M | $24M | $23M | · | $17M | $16M | $11M | · | $5M | |
| Prepaid Expense | $46M | $47M | $44M | $43M | $45M | $42M | $40M | $40M | $35M | $39M | · | $38M | $37M | $39M | · | $46M | |
| Current Assets | $718M | $835M | $942M | $1.03B | $1.02B | $969M | $966M | $1.07B | $632M | $664M | · | $704M | $757M | $792M | · | $785M | |
| PP&E (Net) | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | · | $17M | $20M | $21M | · | $25M | |
| PP&E (Gross) | · | · | $71M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $60M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $10M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Assets | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Accounts Payable | $16M | $14M | $18M | $20M | $18M | $14M | $17M | $17M | $10M | $11M | · | $13M | $12M | $9M | · | $10M | |
| Accrued Liabilities | $35M | $26M | $45M | $37M | $35M | $21M | $47M | $33M | $37M | $25M | · | $30M | $29M | $22M | · | $30M | |
| Current Liabilities | $70M | $59M | $82M | $75M | $70M | $52M | $81M | $119M | $63M | $52M | · | $58M | $55M | $45M | · | $54M | |
| Capital Leases | $12M | $17M | $22M | $27M | $31M | $36M | $40M | $45M | $49M | $53M | · | $61M | $65M | $68M | · | $75M | |
| Other Non-current Liabilities | $240.0K | $90.0K | $90.0K | $90.0K | $101.0K | $880.0K | $880.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $82M | $76M | $104M | $101M | $102M | $89M | $122M | $165M | $113M | $106M | · | $120M | $121M | $115M | · | $130M | |
| Retained Earnings | $-762M | $-661M | $-562M | $-454M | $-350M | $-238M | $-149M | $-52M | $-1.00B | $-904M | · | $-727M | $-635M | $-552M | · | $-507M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | · | $802M | $802M | $802M | · | $802M | |
| Stockholders' Equity | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $661M | $744M | $811M | $887M | $964M | $1.04B | $1.10B | $1.05B | |
| Liabilities + Equity | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Shares Outstanding | 59,604,830 | 59,341,338 | 58,448,592 | 58,279,876 | 58,038,545 | 57,886,781 | 57,156,285 | 57,021,543 | 56,875,079 | 56,751,511 | 72,161,489 | 55,883,973 | 55,734,775 | 55,541,367 | 71,256,118 | 54,894,031 |
현금 흐름 9
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $16M | $16M | $14M | $12M | $15M | $11M | $11M | $11M | $12M | $9M | $14M | $9M | $12M | $10M | $11M | $11M | |
| Operating Cash Flow | $-57M | $-119M | $-96M | $-88M | $-77M | $-111M | $-133M | $-84M | $-73M | $-100M | $-72M | $-62M | $-67M | $-95M | $-66M | $-71M | |
| CapEx | $1M | $769.0K | $1M | $2M | $875.0K | $766.0K | $967.0K | $419.0K | $158.0K | $141.0K | $234.0K | $369.0K | $-3.0K | $399.0K | $113.0K | $38.0K | |
| Investing Cash Flow | $40M | $141M | $90M | $96M | $79M | $113M | $-49M | $251M | $37M | $125M | $96M | $39M | $47M | $58M | $83M | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $3M | $2M | $3M | $4M | $65.0K | $2M | $5M | $3M | $1M | $6M | $847.0K | $2M | $237.0K | $2M | $22.0K | $1M | |
| Net Change in Cash | $-14M | $24M | $-4M | $12M | $2M | $3M | $-177M | $169M | $-34M | $31M | $24M | $-20M | $-19M | $-35M | $17M | $34M | |
| Taxes Paid | $70.0K | $4.0K | $-940.0K | $65.0K | $1M | $188.0K | $44M | $-34.0K | $-78.0K | $-525.0K | $-17.0K | $785.0K | $801.0K | $0 | · | $98.0K | |
| Free Cash Flow | · | $-120M | · | · | · | $-112M | · | · | · | $-100M | · | · | · | $-96M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| Net Margin | -225.1% | -477.7% | · | -803.0% | -899.4% | -1023.2% | · | 10574.7% | -1115.7% | -995.8% | · | -1234.3% | -1248.6% | -1444.4% | · | -2325.0% | |
| Pretax Margin | · | · | · | -803.0% | · | · | · | 11167.3% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| ROA | -7.8% | -7.2% | · | -6.5% | -10.0% | -7.4% | · | 67.7% | -10.3% | -8.2% | · | -8.3% | -7.2% | -6.5% | · | -6.0% | |
| ROE | -8.4% | -7.7% | · | -7.1% | -11.0% | -8.1% | · | 75.4% | -11.8% | -9.2% | · | -9.4% | -8.0% | -7.2% | · | -6.7% | |
| ROIC | · | · | · | -9.1% | · | · | · | -6.0% | · | · | · | · | · | · | · | · |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 14.2 | · | 13.8 | 14.5 | 18.5 | · | 9.0 | 10.1 | 12.8 | · | 12.1 | 13.7 | 17.5 | · | 14.6 | |
| Quick Ratio | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.5 | · | 2.1 | 1.3 | 2.3 | · | 1.1 | 1.5 | 2.3 | · | 2.3 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $91M | $55M | · | $43M | $39M | $34M | · | $33M | $31M | $28M | · | $23M | $21M | $16M | · | $10M | |
| Net Income TTM | $-415M | $-404M | · | $643M | $650M | $681M | · | $679M | $-353M | $-338M | · | $-338M | $-338M | $-349M | · | $-357M | |
| Market Cap | $2.21B | $2.01B | · | $2.34B | $1.93B | $1.70B | · | $2.53B | $2.45B | $1.66B | · | $1.38B | $1.58B | $1.28B | · | $1.55B | |
| P/E | -5.2 | -4.9 | · | 3.7 | 3.0 | 2.5 | · | 3.9 | -6.9 | -4.8 | · | -4.1 | -4.6 | -3.6 | · | -4.3 | |
| P/S | 24.4 | 36.6 | · | 54.4 | 49.8 | 49.2 | · | 76.4 | 79.3 | 59.5 | · | 59.5 | 73.7 | 82.1 | · | 156.3 | |
| P/B | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Tangible Book | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Cash Flow | · | -16.9 | · | · | · | -15.2 | · | · | · | -16.6 | · | · | · | -13.4 | · | · | |
| P / FCF | · | -16.8 | · | · | · | -15.1 | · | · | · | -16.6 | · | · | · | -13.3 | · | · | |
| Earnings Yield | -19.1% | -20.5% | · | 27.3% | 33.2% | 39.4% | · | 25.8% | -14.6% | -20.8% | · | -24.7% | -21.7% | -27.8% | · | -23.5% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $54M | $36M | $27M | $14M | $0 |
| 영업이익률 % | -873.9% | -1166.5% | -1459.5% | -2732.1% | — |
| 순이익 | $-413M | $674M | $-352M | $-232M | $1.60B |
| 희석 EPS | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 |
| 당좌 비율 | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-377M | $-392M | $-297M | $-314M | $-413M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 265개의 제출자 · $2.0B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 46 (+6 이전 분기 대비) | 30 (-2 이전 분기 대비) | 95 (+17 이전 분기 대비) | 62 (-28 이전 분기 대비) | +7.0M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $219,594,714 | 5,917,400 | 11.16% | 주식 |
| STATE STREET CORP | $131,144,972 | 3,533,633 | 6.67% | 주식 |
| Lynx1 Capital Management LP | $126,505,652 | 3,408,937 | 6.43% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107,552,091 | 2,898,197 | 5.47% | 주식 |
| ARMISTICE CAPITAL, LLC | $104,279,100 | 2,810,000 | 5.30% | 콜 옵션 |
| VANGUARD CAPITAL MANAGEMENT LLC | $99,523,268 | 2,681,845 | 5.06% | 주식 |
| ARMISTICE CAPITAL, LLC | $89,064,000 | 2,400,000 | 4.53% | 주식 |
| Erste Asset Management GmbH | $81,972,396 | 2,154,900 | 4.17% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $78,332,000 | 2,110,809 | 3.98% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51,046,957 | 1,375,558 | 2.60% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $50,151,466 | 1,351,093 | 2.55% | 주식 |
| ADAR1 Capital Management, LLC | $47,799,647 | 1,288,053 | 2.43% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $44,225,805 | 1,191,749 | 2.25% | 주식 |
| GOLDMAN SACHS GROUP INC | $36,642,971 | 987,415 | 1.86% | 주식 |
| D. E. Shaw & Co., Inc. | $34,087,168 | 918,544 | 1.73% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $30,078,768 | 810,530 | 1.53% | 주식 |
| Foresite Capital Management VI LLC | $29,131,350 | 785,000 | 1.48% | 주식 |
| CITADEL ADVISORS LLC | $26,154,683 | 704,788 | 1.33% | 주식 |
| Parkman Healthcare Partners LLC | $24,828,297 | 669,046 | 1.26% | 주식 |
| SCS Capital Management LLC | $22,742,864 | 612,850 | 1.16% | 주식 |
| Qube Research & Technologies Ltd | $22,178,346 | 597,638 | 1.13% | 주식 |
| Defilade Capital Management, L.P. | $20,293,529 | 546,848 | 1.03% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19,969,930 | 538,128 | 1.02% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $19,905,062 | 536,380 | 1.01% | 주식 |
| Rock Springs Capital Management LP | $19,763,413 | 532,563 | 1.00% | 주식 |
| Schonfeld Strategic Advisors LLC | $19,300,279 | 520,083 | 0.98% | 주식 |
| Point72 Asset Management, L.P. | $18,790,426 | 506,344 | 0.96% | 주식 |
| JANE STREET GROUP, LLC | $18,280,312 | 492,598 | 0.93% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $14,690,661 | 395,868 | 0.75% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $13,876,579 | 373,931 | 0.71% | 주식 |
| KENNEDY CAPITAL MANAGEMENT LLC | $13,850,565 | 373,230 | 0.70% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $13,342,901 | 359,550 | 0.68% | 주식 |
| Squarepoint Ops LLC | $11,917,431 | 321,138 | 0.61% | 주식 |
| JPMORGAN CHASE & CO | $11,853,074 | 309,008 | 0.60% | 주식 |
| Ensign Peak Advisors, Inc | $11,045,049 | 297,630 | 0.56% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $9,996,803 | 269,383 | 0.51% | 주식 |
| ALGERT GLOBAL LLC | $9,203,540 | 248,007 | 0.47% | 주식 |
| JANE STREET GROUP, LLC | $7,974,939 | 214,900 | 0.41% | 풋 옵션 |
| Palo Alto Investors LP | $7,926,733 | 213,601 | 0.40% | 주식 |
| Tetragon Partners GP Ltd | $7,629,037 | 205,579 | 0.39% | 주식 |
| AXA Investment Managers S.A. | $7,131,875 | 177,675 | 0.36% | 주식 |
| Cutter Capital Management, LP | $6,895,755 | 235,350 | 0.35% | 주식 |
| BlackRock, Inc. | $6,545,388 | 176,378 | 0.33% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6,334,677 | 170,700 | 0.32% | 콜 옵션 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $6,306,139 | 169,931 | 0.32% | 주식 |
| FIRST TRUST ADVISORS LP | $6,144,933 | 165,587 | 0.31% | 주식 |
| Ishara Investments LP | $6,086,040 | 164,000 | 0.31% | 주식 |
| GROUP ONE TRADING LLC | $5,640,497 | 151,994 | 0.29% | 주식 |
| BOOTHBAY FUND MANAGEMENT, LLC | $5,562,269 | 149,886 | 0.28% | 주식 |
| BANK OF AMERICA CORP /DE/ | $5,505,083 | 148,345 | 0.28% | 주식 |
| MARSHALL WACE, LLP | $5,150,868 | 138,800 | 0.26% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5,080,359 | 136,900 | 0.26% | 풋 옵션 |
| AMERICAN CENTURY COMPANIES INC | $4,991,740 | 134,512 | 0.25% | 주식 |
| Man Group plc | $4,617,931 | 124,439 | 0.23% | 주식 |
| ArrowMark Colorado Holdings LLC | $4,368,367 | 117,714 | 0.22% | 주식 |
| Pictet Asset Management Holding SA | $4,247,606 | 111,861 | 0.22% | 주식 |
| Swiss National Bank | $4,143,703 | 111,660 | 0.21% | 주식 |
| CAPITAL FUND MANAGEMENT S.A. | $3,862,408 | 104,080 | 0.20% | 주식 |
| Assenagon Asset Management S.A. | $3,857,770 | 103,955 | 0.20% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3,700,831 | 99,726 | 0.19% | 주식 |
| Knott David M Jr | $3,527,602 | 95,058 | 0.18% | 주식 |
| Trexquant Investment LP | $3,471,232 | 93,539 | 0.18% | 주식 |
| CITADEL ADVISORS LLC | $3,402,987 | 91,700 | 0.17% | 콜 옵션 |
| Jain Global LLC | $3,401,020 | 91,647 | 0.17% | 주식 |
| Caligan Partners LP | $3,339,900 | 90,000 | 0.17% | 콜 옵션 |
| CITADEL ADVISORS LLC | $3,295,368 | 88,800 | 0.17% | 풋 옵션 |
| CITIGROUP INC | $3,182,331 | 85,754 | 0.16% | 주식 |
| RHUMBLINE ADVISERS | $2,948,045 | 79,441 | 0.15% | 주식 |
| Bank of New York Mellon Corp | $2,916,846 | 78,600 | 0.15% | 주식 |
| Campbell & CO Investment Adviser LLC | $2,712,555 | 73,095 | 0.14% | 주식 |
| Exome Asset Management LLC | $2,616,255 | 70,500 | 0.13% | 주식 |
| Edgestream Partners, L.P. | $2,604,936 | 70,195 | 0.13% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $2,441,059 | 65,779 | 0.12% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2,319,520 | 68,564 | 0.12% | 주식 |
| TWO SIGMA ADVISERS, LP | $2,319,144 | 85,200 | 0.12% | 주식 |
| ALPS ADVISORS INC | $2,228,789 | 60,059 | 0.11% | 주식 |
| Seven Fleet Capital Management LP | $2,111,559 | 56,900 | 0.11% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $2,092,859 | 61,864 | 0.11% | 주식 |
| Rafferty Asset Management, LLC | $2,062,574 | 55,580 | 0.10% | 주식 |
| Engineers Gate Manager LP | $2,000,674 | 53,912 | 0.10% | 주식 |
| WELLS FARGO & COMPANY/MN | $1,935,843 | 52,165 | 0.10% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1,931,576 | 52,050 | 0.10% | 주식 |
| XTX Topco Ltd | $1,869,082 | 50,366 | 0.10% | 주식 |
| Caption Management, LLC | $1,855,500 | 50,000 | 0.09% | 콜 옵션 |
| Tetragon Partners GP Ltd | $1,855,500 | 50,000 | 0.09% | 콜 옵션 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1,846,742 | 49,764 | 0.09% | 주식 |
| BARCLAYS PLC | $1,725,651 | 46,501 | 0.09% | 주식 |
| Quantinno Capital Management LP | $1,614,805 | 43,514 | 0.08% | 주식 |
| MARTINGALE ASSET MANAGEMENT L P | $1,596,064 | 43,009 | 0.08% | 주식 |
| IEQ CAPITAL, LLC | $1,499,392 | 40,404 | 0.08% | 주식 |
| Kodai Capital Management LP | $1,485,276 | 50,692 | 0.08% | 주식 |
| Virtus Investment Advisers, LLC | $1,464,843 | 39,473 | 0.07% | 주식 |
| Caption Management, LLC | $1,456,530 | 39,249 | 0.07% | 주식 |
| JANE STREET GROUP, LLC | $1,451,001 | 39,100 | 0.07% | 콜 옵션 |
| FMR LLC | $1,446,325 | 38,974 | 0.07% | 주식 |
| Aquatic Capital Management LLC | $1,433,448 | 38,627 | 0.07% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1,400,049 | 37,727 | 0.07% | 주식 |
| VANGUARD GROUP INC | $1,308,928 | 48,087 | 0.07% | 주식 |
| EDGEWOOD MANAGEMENT LLC | $1,298,850 | 35,000 | 0.07% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1,298,776 | 34,998 | 0.07% | 주식 |
회사 내부자 33 명의 내부자 · 12 임원 · 19 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Brian Goff | Chief Executive Officer | 2026년 6월 18일 A | — | 0 | 0 | $0 |
| Cecilia Jones | Chief Financial Officer | 2026년 6월 18일 A | — | 0 | 0 | $0 |
| Andrew Hirsch | Chief Financial Officer | 2019년 4월 22일 A | 12,374 | 0 | 0 | $0 |
| John Duncan Higgons | Chief Operating Officer | 2016년 1월 4일 M | 120,834 | 0 | 0 | $0 |
| Krishnan Viswanadhan | Chief Strategy and Operations | 2026년 6월 18일 A | — | 0 | 0 | $0 |
| Tsveta Milanova | Chief Commercial Officer | 2026년 6월 18일 A | — | 0 | 0 | $0 |
| James William Burns | Chief Legal Officer | 2026년 6월 18일 A | — | 0 | 0 | $0 |
| Scott Biller | Chief Scientific Officer | 2019년 4월 5일 M | 26,511 | 0 | 0 | $0 |
| Christopher Bowden | Chief Medical Officer | 2019년 4월 1일 M | 7,238 | 0 | 0 | $0 |
| Steven L. Hoerter | Chief Commercial Officer | 2019년 3월 4일 M | 10,941 | 0 | 0 | $0 |
| Carman Alenson | Principal Accounting Officer | 2019년 2월 22일 A | 2,796 | 0 | 0 | $0 |
| Glenn Goddard | Senior Vice President, Finance | 2016년 2월 16일 A | 0 | 0 | 0 | $0 |
| Adams Catherine Owen | 이사 | 2026년 6월 18일 A | 10,865 | 0 | 0 | $0 |
| Rahul D. Ballal | 이사 | 2026년 6월 18일 A | 15,230 | 0 | 0 | $0 |
| David Scadden | 이사 | 2026년 6월 18일 A | 20,419 | 0 | 0 | $0 |
| Maykin Ho | 이사 | 2026년 6월 18일 A | 19,848 | 0 | 0 | $0 |
| Cynthia Smith | 이사 | 2026년 6월 18일 A | 15,230 | 0 | 0 | $0 |
| Jacqualyn A Fouse | 이사 | 2026년 6월 18일 A | 154,156 | 0 | 0 | $0 |
| Kaye I Foster-Cheek | 이사 | 2026년 6월 18일 A | 10,284 | 0 | 0 | $0 |
| Jeffrey D Capello | 이사 | 2026년 6월 18일 A | 10,865 | 0 | 0 | $0 |
| Paul J Clancy | 이사 | 2019년 5월 31일 M | 1,400 | 0 | 0 | $0 |
| Ian T Clark | 이사 | 2019년 5월 31일 M | 1,400 | 0 | 0 | $0 |
| John Maraganore | 이사 | 2019년 5월 31일 M | 37,609 | 0 | 0 | $0 |
| David P Schenkein | 이사 | 2019년 2월 22일 A | 89,503 | 0 | 0 | $0 |
| Lewis Clayton Cantley Jr. | 이사 | 2017년 12월 7일 S | 79,515 | 0 | 0 | $0 |
| Robert Nelsen | 이사 | 2017년 3월 6일 S | 0 | 0 | 0 | $0 |
| Douglas G. Cole | 이사 | 2016년 8월 10일 J | 2,778 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | 이사 | 2016년 6월 21일 A | 101,009 | 0 | 0 | $0 |
| Perry A Karsen | 이사 | 2015년 6월 23일 A | — | 0 | 0 | $0 |
| Kevin P Starr | 이사 | 2015년 2월 19일 J | 184,386 | 0 | 0 | $0 |
| Celgene European Investment Co LLC | 10% 소유주 | 2014년 12월 16일 P | 1,231,778 | 0 | 0 | $0 |
| Sarah Gheuens | — | 2026년 8월 4일 S | 54,645 | 0 | 2 | $-1,064,903 |
| Jay T. Backstrom | — | 2026년 7월 8일 M | 1,447 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 3 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION, CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC | 2021년 4월 5일 | — | 최초 제출 | — | SEC |
| CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 제출 서류 | 2019년 11월 14일 | — | 최초 제출 | 자본 구조 | SEC |
| CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 제출 서류 | 2014년 12월 17일 | — | 최초 제출 | 자본 구조 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 57 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.64% | 34,703 NS | 2026년 4월 30일 | N-PORT |
| SBIO · ALPS ETF Trust | 1.10% | 60,392 NS | 2026년 5월 31일 | N-PORT |
| HAPS · Harbor ETF Trust | 0.77% | 43,269 NS | 2026년 4월 30일 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.60% | 110,585 NS | 2026년 4월 30일 | N-PORT |
| AGNG · Global X Funds | 0.28% | 7,695 NS | 2026년 5월 31일 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.27% | 101,599 NS | 2026년 4월 30일 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.12% | 109,727 NS | 2026년 5월 31일 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.09% | 40,934 NS | 2026년 4월 30일 | N-PORT |
| BIB · ProShares Trust | 0.09% | 2,166 NS | 2026년 5월 31일 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.08% | 22,172 NS | 2026년 4월 30일 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.06% | 9,472 NS | 2026년 4월 30일 | N-PORT |
| RSSL · Global X Funds | 0.05% | 24,449 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.04% | 2,658 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.04% | 193,306 NS | 2026년 4월 30일 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.04% | 280,734 NS | 2026년 5월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 25,231 NS | 2026년 4월 30일 | N-PORT |
| UWM · ProShares Trust | 0.02% | 2,079 NS | 2026년 5월 31일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.02% | 2,762 NS | 2026년 4월 30일 | N-PORT |
| URTY · ProShares Trust | 0.02% | 2,105 NS | 2026년 5월 31일 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 5,903 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 2,328 NS | 2026년 5월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 136,570 NS | 2026년 4월 30일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 8,867 NS | 2026년 4월 30일 | N-PORT |
| HDG · ProShares Trust | 0.01% | 53 NS | 2026년 5월 31일 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 25,095 NS | 2026년 5월 31일 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.01% | 1,068 NS | 2026년 5월 31일 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 4,329 NS | 2026년 4월 30일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 17,627 NS | 2026년 4월 30일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 19,324 NS | 2026년 4월 30일 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 34,617 NS | 2026년 5월 31일 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 9,999 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VB · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VBK · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 2026년 7월 15일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| ITOT · iShares Trust | — | — | 2026년 8월 5일 | 일간 |
| IWV · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWN · iShares Trust | — | — | 2026년 8월 17일 | 일간 |
| IWO · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWM · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IBB · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026년 8월 4일 | 일간 |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 2026년 7월 13일 | 일간 |
| VHT · VANGUARD WORLD FUND | — | — | 2026년 7월 20일 | 일간 |
| ESGV · VANGUARD WORLD FUND | — | — | 2026년 7월 30일 | 일간 |